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Summary Background: Where evidence is required for disease-area prioritisation
(e.g. by national policymakers), impact on health related quality of life (HRQoL) can
be considered equitably across diseases using quantitative data from generic HRQoL
instruments. Before this can take place, it must be shown that the instrument
captures HRQoL impairment associated with each disease area.
Aim: To ascertain whether the HRQoL impairment associated with respiratory
disease can be represented by responses to EQ-5D, a generic HRQoL questionnaire.
Method: EQ-5D and a respiratory health questionnaire were sent to 10,471 adults
registered with two general practices in Manchester, UK. EQ-5D examines 5 domains
(mobility, self-care, usual activities, pain/discomfort and anxiety/depression) and
includes an overall rating via visual analogue scale. Societal valuations of domain
responses were also considered.
Results: HRQoL was substantially reduced in respondents who were likely to have
obstructive airways disease (mean EQ-5Dindex 0.63 compared to 0.82, t-test Po0:001;
mean EQ-5Dvas 62.7 compared to 77.6, t-test Po0:001) and was negatively associated
with respiratory symptoms, older age and female gender. The association with
respiratory problems remained following stratification by age and gender. The deficit
in HRQoL associated with increasing age was more pronounced in those likely to have
obstructive airways disease.
Conclusion: HRQoL measured using EQ-5D is substantially reduced in respondents
with respiratory symptoms enabling use of the instrument in inter-disease
comparisons.
& 2003 Elsevier Ltd. All rights reserved.
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Introduction
Quantification of the wider burden of illness on
society, including consideration of health-related
quality of life (HRQoL), has become more important
as the overall health of the population has
improved. Methods of comparison of HRQoL are
divided broadly into generic and disease-specific
subtypes. Generic instruments examine broad
domains that are not specific to any single disease
area, allowing the comparison of individuals across
disease areas, taking account of co-morbidity and
using a common scale. Thus, where evidence is
required for prioritisation of disease areas (for
example by national policymakers), potential im-
pact on HRQoL can be considered equitably across
diseases using quantitative data. In contrast,
disease-specific instruments are generally more
sensitive instruments but are less appropriate in
general population studies which include large
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numbers of patients who do not have the disease in
question.
Prior to comparison of generic HRQoL across
disease areas, the ability of the generic instrument
to represent HRQoL in each disease area should be
examined. EQ-5D1 was chosen for the present study
because it generates a single index of generic
HRQoL; a requirement for use in economic
analyses (such as the QALY or quality adjusted
life year approach) across diseases. Other advan-
tages include its brevity (estimated to take less
than 5min to complete2) and ease of administra-
tion. So far, although EQ-5D has been used in
general populations without reference to a specific
disease area,3,4 and in secondary care patients,5,6
it has not been tested in a general population with
reference to clinical symptoms of respiratory
disease.
Aim
To ascertain whether the health related quality of
life impairment associated with respiratory disease
is represented by responses to EQ-5D, a generic
health related quality of life questionnaire.
Method
A postal questionnaire comprising EQ-5D7 and a
modified version of the European Community
Respiratory Health Questionnaire8 (by the
addition of questions regarding family history
and smoking habits) was sent in 2001 to all
patients (10,471) over the age of 16 years
registered with two neighbouring general
practices in South Manchester. A covering
letter on practice headed paper was included, with
the respondents name and address printed indivi-
dually, describing the questionnaire survey and its
purpose in research and resource planning. A post-
paid reply envelope was included. Up to two
reminders were sent, 4 and 8 weeks after the
initial mailing.
The respiratory questionnaire asks about the
occurrence of respiratory symptoms over the last
12 months and the presence of risk factors for
respiratory disease.9 The likelihood of a patient
having obstructive airways disease was assessed
according to the number of symptoms/risk factors
reported from six key questions. Validation testing
found the reporting of four or more symptoms/risk
factors gave a positive predictive value of 0.75 for
meriting a trial of obstructive airways disease
medication.10 The six key questions were as
follows:
(1) Have you had wheezing or whistling in your
chest at any time in the last 12 months?
(2) Have you woken up with a feeling of tightness
in your chest in the last 12 months?
(3) Have you been woken by an attack of
shortness of breath at any time in the last 12
months?
(4) Have you been woken by an attack of coughing
at any time in the last 12 months?
(5) Has any person in your family (parents, grand-
parents, sisters, brothers, or your children) had
asthma?
(6) Have you ever had hay fever or eczema?
Thus respondents who reported four or more of
these symptoms/risk factors were termed ‘likely
obstructive airways disease’.
EQ-5D was designed for self-completion and asks
respondents to rate their function via a single
question in each of 5 domains. Domain response
combinations are conventionally reported in the
order mobility (MO), self-care (SC), usual activities
(UA), pain/discomfort (PD) and anxiety/depression
(AD). HRQoL is rated at one of three levels: (1)
(best possible, no problems), (2) (intermediate,
some problems) or (3) (worst possible, severe
problems), producing 243 (35) combinations ranging
from 11111 (best possible, no problems on any
domain) to 33333 (worst possible, severe problems
on all domains).
The modelling of valuations for a subset of
combinations of responses (health states) has been
achieved by surveying members of the public and
applying preference analysis tools such as the time
trade-off technique or the standard gamble. The
values for the sample of states are extrapolated to
form a ‘tariff of valuations’ for all possible
combinations of responses. The values used in this
study are those of Dolan et al.11,12 ranging from
0.59 to 1.00, where 0 represents a state
equivalent to death, a negative value represents
a state ‘worse than death’ and 1 represents
‘perfect health’. This measure of HRQoL is referred
to as EQ-5Dindex.
The second part of the instrument requires
participants to rate their own quality of life on a
thermometer-like 20 cm visual analogue scale (VAS)
from 0 (‘worst imaginable health state’) to 100
(‘best imaginable health state’) and is referred to
as EQ-5Dvas.
Differences in proportions for categorical vari-
ables were examined using w2 tests. Differences in
the two measures of health-related quality of life
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(single index value, EQ-5Dindex and visual analogue
scale, EQ-5Dvas) between subgroups were examined
using t-tests for differences in means (the reasons
for this choice are discussed later) and Kruskall–
Wallis tests for differences in ordinal subgroups.
Associations between age and HRQoL were exam-
ined using Spearman’s rank correlation coefficient.
Analyses were conducted using SPSS for Windows
software.13 Ethical approval for this study was
obtained from South Manchester Local Research
Ethics Committee.
Results
In total, 10,471 questionnaires were sent out. After
two reminders, although 6828 responses were
received, only 5944 (87%) had complete data for
EQ-5D. This represents an overall usable response
rate of 56.8%.
Respondents ranged in age from 16 to 99 with a
mean age of 48.5 years (SD 19.4), with more females
(54.9%) than males (45.1%). Non-respondents were
younger than respondents (mean age 37.6 com-
pared to 48.5, t-test Po0:001) and more likely to
be male (55.1%, w2 95.6 Po0:001). A significantly
smaller proportion of non-respondents were aged
60 or more than for respondents (9.2% vs 30.1% w2
587.7 Po0:001).
Of those who returned the questionnaire, rela-
tively small proportions failed to complete the EQ-
5D domain questions. The highest proportion of
missing values was found for the self-care domain
(5.7%), followed by anxiety/depression (4.4%),
usual activities (4.3%), pain/discomfort (4.1%) and
mobility (3.9%). A larger proportion (6.3%) of
respondents did not complete the visual analogue
scale (EQ-5Dvas).
Table 1 shows the proportion of respondents
reporting problems in each domain by gender and
age. In general, women reported problems in one
or more of the five domains more frequently than
men and recorded significantly lower values on EQ-
5Dvas. Both EQ-5Dindex and EQ-5Dvas were found to
decrease significantly with advancing age although
the correlations were modest (Spearman’s
rho¼0.41, Po0:001 and 0.34, Po0:001; re-
spectively).
Table 2 shows the proportion of respondents
reporting problems in each domain by reported
respiratory symptoms and likely obstructive air-
ways disease (four or more symptoms/risk factors).
The presence of any of the respiratory symptoms
was associated with problems in the five EQ-5D
domains and thus respiratory symptoms were also
associated with lower values of both EQ-5Dindex
and EQ-5Dvas. Those considered likely to have
obstructive airways disease (reporting four or more
symptoms/risk factors) also had significantly lower
mean domain derived scores and visual analogue
scale scores (mean EQ-5Dindex 0.63 compared to
0.82, t-test Po0:001; mean EQ-5Dvas 62.7 com-
pared to 77.6, t-test Po0:001).
Figures 1 and 2 show the frequency distributions
of EQ-5Dindex in those defined as likely and unlikely
obstructive airways disease respectively. Both
distributions were markedly skewed towards the
maximal value of 1.0, although this was more
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Table 1 The proportion of respondents reporting problems (level 2 or 3) in each domain by age and gender along
with the mean value of EQ-5Dindex and the mean value for EQ-5Dvas.
n % Percentage of respondents reporting a problem Mean
MO SC UA PD AD EQ-5Dindex EQ-5Dvas
Total 6828 100 27.0 10.4 26.7 41.4 31.4 0.78 74.58
Women 3748 54.9 29.4 12.0 29.8 44.7 37.1 0.78 74.57
Men 3080 45.1 26.6 9.9 25.7 41.4 27.9 0.80 76.35
P 0.01 o0.01 o0.01 o0.01 o0.01 o0.01 o0.01
Age 16–24 1205 17.6 5.6 1.8 7.5 14.6 16.5 0.93 84.25
25–34 1189 17.4 8.2 2.4 11.7 21.9 26.6 0.90 81.32
35–44 1029 15.1 13.7 5.2 17.3 32.3 32.7 0.84 78.24
45–54 908 13.3 25.1 10.8 28.4 47.6 38.0 0.77 75.12
55–64 872 12.8 46.8 17.1 44.1 65.4 41.4 0.67 70.03
65–74 757 11.1 50.2 18.4 42.4 63.7 36.6 0.70 68.77
75–84 721 10.6 56.8 25.6 49.3 65.8 48.1 0.64 63.85
85þ 147 2.2 80.6 42.2 27.9 74.4 32.9 0.50 58.17
P o0.01 o0.01 o0.01 o0.01 o0.01 o0.01 o0.01
MO¼mobility, SC¼ self-care, UA¼ usual activities, PD¼pain/discomfort, AD¼ anxiety/depression.
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pronounced for those unlikely to have obstructive
airways disease.
The corresponding frequency distributions for
EQ-5Dvas are shown in Figs. 3 and 4. Among those
who did record a value for EQ-5Dvas there was
considerable terminal digit preference, with a
majority of respondents (77.9%) choosing a value
ending in 0 or 5. This resulted in non-normal
distributions of values irrespective of respiratory
disease status. The distribution of EQ-5Dvas in those
unlikely to have obstructive airways disease was
skewed towards maximal HRQoL, although less so
than EQ-5Dindex in this group. However, the dis-
tribution of EQ-5Dvas in those likely to have
obstructive airways disease more closely resembled
a normal distribution.
Tables 3 and 4 show mean values of EQ-5Dindex
and EQ-5Dvas in those deemed likely and not likely
to have obstructive airways disease respectively,
stratified by age and gender for respondents aged
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Table 2 The proportion of respondents reporting problems (level 2 or 3) in each domain by reported respiratory
symptoms along with the mean value of EQ-5Dindex, and the mean value for EQ-5Dvas.
n % Percentage of respondents reporting a problem Mean
MO SC UA PD AD EQ-5Dindex EQ-5Dvas
Wheeze Yes 2265 38.8 42.6 18.4 43.4 60.0 48.3 0.67 65.37
No 4430 66.2 20.3 7.3 19.6 34.3 24.8 0.84 79.42
P o0.01 o0.01 o0.01 o0.01 o0.01 o0.01 o0.01
Chest Tightness Yes 1391 20.7 48.6 20.8 49.9 65.6 52.3 0.63 62.58
No 5332 79.3 22.3 8.3 21.7 36.9 27.6 0.82 77.87
P o0.01 o0.01 o0.01 o0.01 o0.01 o0.01 o0.01
Shortness of breath Yes 955 14.2 58.4 26.5 59.2 71.5 56.4 0.58 58.60
No 5765 85.8 22.7 8.4 22.4 38.1 28.8 0.82 77.35
P o0.01 o0.01 o0.01 o0.01 o0.01 o0.01 o0.01
Cough Yes 2408 35.7 38.5 15.4 39.0 55.2 43.9 0.83 67.71
No 4335 64.3 22.1 8.5 21.5 36.1 26.5 0.71 78.48
P o0.01 o0.01 o0.01 o0.01 o0.01 o0.01 o0.01
Likely OAD Yes 1054 16.5 46.7 20.2 48.8 63.0 54.1 0.63 62.70
No 5321 83.5 22.8 8.3 22.2 37.7 27.6 0.82 77.59
P o0.01 o0.01 o0.01 o0.01 o0.01 o0.01 o0.01
MO¼mobility, SC¼ self-care, UA¼ usual activities, PD¼pain/discomfort, AD¼ anxiety/depression, OAD¼ obstructive airways
disease.
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Figure 1 Frequency distribution of EQ-5Dindex in respon-
dents likely to have obstructive airways disease.
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Figure 2 Frequency distribution of EQ-5Dindex in respon-
dents not likely to have obstructive airways disease.
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up to 84 years old. The number of respondents aged
85 years and over was too small to permit mean-
ingful stratified analysis. In all cases, HRQoL was
reduced in those respondents with likely obstruc-
tive airways disease compared to respondents of
the same gender and age category who were
unlikely to have obstructive airways disease. The
deficit in HRQoL associated with increasing age was
much more pronounced in those who reported four
or more respiratory symptoms or risk factors.
Discussion
This study has found that health related quality of
life measured using the EuroQol EQ-5D instrument
is substantially reduced in respondents who report
common respiratory symptoms and in those who are
likely to have obstructive airways disease. The
association with obstructive airways disease re-
mained following stratification of the analysis by
age and gender. In addition, the deficit in HRQoL
associated with respiratory symptoms increased
with increasing age. Confirmation that EQ-5D is
showing impaired HRQoL in those with respiratory
problems will enable its relationship with a disease-
specific instrument to be quantified.
The apparent increase in the impact of respira-
tory symptoms on generic HRQoL with advancing
age could be due to a number of factors. Firstly, it
is possible that there are differences in the
respiratory symptoms themselves in older respon-
dents; for example there is likely to be a higher
prevalence of COPD compared with asthma and the
differences in symptomatology may account for this
interaction. Secondly, the likelihood of a respon-
dent having one or more co-morbid conditions is
likely to increase with advancing age and thus lead
to greater impairment of HRQoL. In addition,
factors associated with ageing may lower the
extent to which respiratory (and other) symptoms
can be tolerated. Other factors such as the
perception that it is natural for old people to have
problems in the domains in question may have led
to higher reporting and thus greater apparent
impairment of HRQoL. However, it is also possible
that other perceptions play a partFfor example
that although the respondent may have some
difficulties, they are on a par with others of their
age. This is likely to be more relevant when
considering a respondent’s overall rating of their
HRQoL on EQ-5Dvas.
A similar interaction where individuals with
asthma had a greater worsening of HRQoL with
advancing age has been reported previously
using a disease-specific questionnaire (St George’s
Respiratory Questionnaire)14 and was considered
to be a reflection of co-morbidity. Co-morbidity
has been found to be a determinant of HRQoL
in older asthma and COPD patients.15 The study by
Ferrer et al.14 generated normative general
population values for a disease-specific instrument
to take account of the fact that even individuals
without formal respiratory disease may report
some degree of impairment on the disease-
specific instrument. This approach could also assist
in the prioritisation of disease areas especially if
the normative values on the disease-specific
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Figure 3 Frequency distribution of EQ-5Dvas in respon-
dents likely to have obstructive airways disease.
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Figure 4 Frequency distribution of EQ-5Dvas in respon-
dents not likely to have obstructive airways disease.
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instrument could be translated to those of a
generic instrument.
A respiratory questionnaire based on one used
widely in previous population surveys (and vali-
dated for this purpose) enabled identification of
respondents with likely obstructive airways dis-
ease, in addition to examining HRQoL in the
presence of respiratory symptoms. The question-
naire was validated for ‘meriting a trial of
obstructive airways disease medication’. The ques-
tions used for categorisation of respiratory disease
focus on asthma symptoms, although respondents
with a diagnosis of COPD (or another respiratory
illness producing similar symptoms) may also be
categorised as likely obstructive airways disease.
The issue of diagnosis and labelling in the setting of
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Table 3 Mean values of EQ-5Dindex (95% confidence interval) by likely diagnosis of obstructive airways disease,
stratified by age and gender.
Age Mean EQ-5Dindex
Females Males
Unlikely OAD Likely OAD Unlikely OAD Likely OAD
16–24 0.94 0.87 0.95 0.87
(0.92–0.95) (0.84–0.91) (0.93–0.97) (0.82–0.92)
25–34 0.91 0.79 0.90 0.84
(0.89–0.92) (0.74–0.85) (0.88–0.92) (0.79–0.88)
35–44 0.87 0.72 0.88 0.63
(0.85–0.89) (0.66–0.78) (0.86–0.90) (0.56–0.71)
45–54 0.80 0.51 0.81 0.55
(0.78–0.83) (0.44–0.59) (0.78–0.84) (0.47–0.63)
55–64 0.72 0.48 0.73 0.46
(0.68–0.75) (0.41–0.56) (0.70–0.77) (0.36–0.55)
65–74 0.70 0.44 0.77 0.57
(0.67–0.74) (0.33–0.55) (0.74–0.80) (0.47–0.67)
75–84 0.68 0.42 0.72 0.44
(0.64–0.72) (0.32–0.53) (0.68–0.76) (0.28–0.59)
OAD¼ obstructive airways disease.
Table 4 Mean values of EQ-5Dvas (95% confidence interval) by likely diagnosis of obstructive airways disease,
stratified by age and gender.
Age Mean EQ-5Dvas
Females Males
Unlikely OAD Likely OAD Unlikely OAD Likely OAD
16–24 83.89 75.66 88.66 76.31
(82.18–85.60) (71.82–79.51) (87.07–90.25) (71.67–80.94)
25–34 82.94 70.02 82.35 68.28
(81.42–84.46) (65.33–74.71) (80.69–84.01) (63.21–73.36)
35–44 81.40 65.50 80.79 63.83
(79.81–82.99) (61.48–69.52) (79.21–82.36) (59.17–68.48)
45–54 77.39 59.58 77.42 58.32
(75.71–79.08) (55.15–64.02) (75.74–79.09) (53.40–63.23)
55–64 73.67 59.84 74.00 51.88
(71.59–75.74) (55.82–63.86) (71.82–76.17) (46.85–56.91)
65–74 69.82 54.45 73.39 55.27
(67.64–72.00) (48.41–60.48) (70.99–75.78) (49.88–60.66)
75–84 64.55 49.98 69.70 51.57
(62.03–67.07) (44.48–55.48) (66.90–72.50) (42.76–60.38)
OAD¼ obstructive airways disease.
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asthma and COPD is controversial. An advantage of
a generic questionnaire that can represent HRQoL
in respondents with respiratory disease is that it
can be applied to all those with symptoms, rather
than those fitting a particular diagnostic pattern.
The consideration of symptoms rather than diag-
nostic label also has the advantage that it can
include those who have hitherto undiagnosed
symptoms. It is these individuals who may be
responsible for Ferrer et al.’s finding of residual
disease-specific HRQoL impairment in a general
population.14
The large population size is a further strength of
this study, and the response rate compares favour-
ably with other population studies both with (26%16
to 39%17) and without additional valuation tasks
(59.6%18 to around 79%19). Additional strategies to
improve the response rate are costly and could
affect the relationship between the General Practi-
tioner (on whose behalf the letters were sent) and
the patient.
The selection of the study population was based
on registration with two particular general prac-
tices and it is possible that this has led to some
selection bias. The age profile of those included in
the analysis was compared with that of the local
population estimates for wards (voting districts) in
England in mid 199820 produced by the Social
Disadvantage Research Group of Oxford University
and found to be very similar. It was not possible to
compare the gender profiles in a similar way, and it
is likely that the study population contained a
higher proportion of females, potentially over-
estimating of the overall quality of life impairment.
Missing data resulted in 13% of the returned
questionnaires being unsuitable for analysis. The
‘self-care’ question was missed significantly more
often, possibly reflecting an unwillingness to report
the implicit dependence on others. A larger
proportion of respondents did not complete the
visual analogue scale. This task is unusual and
respondents may not have fully understood how to
complete it. The provision of an example may
improve response, but it may also have the effect
of introducing bias by implying a ‘correct’ re-
sponse.
Among those who recorded a value for EQ-5Dvas
there was considerable terminal digit preference,
with 77.9% of respondents choosing a value ending
in zero or five. This has been reported in relation to
blood pressure measurement21 but little is known
about its effects in the measurement of HRQoL.
This phenomenon results in a non-normal distribu-
tion of responses which complicates analysis of
both EQ-5Dvas and EQ-5Dindex data. The use of the t-
test for differences in means has been shown to
stand up to violations of normality22 and the use of
mean values also enables comparison with other
publications.
Multivariate analysis may have provided more
detailed evidence of a statistically significant
impairment of HRQoL in those likely to have
obstructive airways disease, but this was not
attempted due to the non-normal distributions of
EQ-5Dindex and EQ-5Dvas. Problems with the non-
normality of the distribution of EQ-5D data are not
unique to this study23,24 and non-parametric meth-
ods have been recommended for use with popula-
tion samples.25
Despite the limitations of this study, it has been
shown that HRQoL impairment associated with the
presence of respiratory symptoms can be repre-
sented by responses to the generic questionnaire
EQ-5D. It is also clear that EQ-5D is a valuable tool
for assessment of generic health-related quality of
life in population surveys. The provision of a
numeric single index measure of HRQoL enables
analysis of individual survey results and also of
longitudinal studies (to examine change within
individuals over time). Further investigation of
EQ-5D in the context of respiratory disease should
be conducted by concurrent administration with a
disease-specific instrument in a population known
to have respiratory problems and analysis of co-
morbidity may shed further light on the interaction
of age and respiratory symptoms.
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